Jaime S. King


  • Health Law: Cases, Materials, and Problems (West Academic 8th ed. 2018) (with Barry R Furrow, Thomas L Greaney, Robert L. Schwartz, Sandra H Johnson, Timothy S Jost, Erin C. Fuse Brown, Brietta R. Clark, Robert Gatter, & Elizabeth Pendo).
Journal Articles

  • Antitrust's Healthcare Conundrum: Cross-Market Mergers and the Rise of System Power, 74 Hastings L.J. 1057 (2023) (with Alexandra D. Montague, Daniel Arnold, & Thomas L. Greaney). FULLTEXT SSRN
  • How Will Draft Merger Guidelines Impact Health Care Markets?, Health Aff. Forefront (Dec. 13) (with Amy Y. Gu & Katherine L. Gudiksen). URL
  • In this Together: International Collaborations for Environmental and Human Health, 51 J.L. Med. & Ethics 271 (2023) (with Joanna Manning, & Alistair Woodward). URL
  • Are State Public Option Health Plans Worth It?, 59 Harv. J. on Legis. 145 (2022) (with Katherine L. Gudiksen & Erin C. Fuse Brown). FULLTEXT SSRN
  • Do State Bans of Most-Favored-Nation Contract Clauses Restrain Price Growth? Evidence From Hospital Prices, 100 Milbank Q. 589 (2022) (with Daniel R. Arnold, Katherine L. Gudiksen, Brent D. Fulton, & Richard M. Scheffler). URL
  • The Rise Of Cross-Market Hospital Systems And Their Market Power In The US, 41 Health Aff. (11) (with Brent D. Fulton et al.). URL
  • States’ Merger Review Authority Is Associated With States Challenging Hospital Mergers, But Prices Continue To Increase, 40 Health Aff. 1836 (2021) (with Brent D. Fulton et al.). FULLTEXT
  • The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs, 39 J. Leg. Med. 95 (2019) (with Katherine L. Gudiksen). FULLTEXT
  • California’s Drug Transparency Law: Navigating the Boundaries of State Authority on Drug Pricing, 37 Health Aff. 1503 (2018). FULLTEXT
  • Don’t Hate the Player; Hate the Game, 70 Annals Emergency Med. 875 (2017) (with Renee Y. Hsia & Brendan G. Carr). FULLTEXT URL
  • The Anti-Competitive Potential of Cross-Market Mergers in Health Care, 11 St. Louis U. J. Health L. & Pol'y 43 (2017) (with Erin C. Fuse Brown). FULLTEXT SSRN
  • The Double-Edged Sword of Health Care Integration: Consolidation and Cost Control, 92 Ind. L.J. 55 (2016) (with Erin C. Fuse Brown). SSRN
  • Whole-Genome Screening of Newborns? The Constitutional Boundaries of State Newborn Screening Programs, 137 Pediatrics S8 (Supp. 1, 2016) (with Monica E. Smith). URL
  • Best Ethical Practices for Clinicians and Laboratories in the Provision of Non–Invasive Prenatal Testing, 33 Prenatal Diagnosis 656 (2013) (with Megan Allyse et al.). URL
  • Clarifying Costs: Can Increased Price Transparency Reduce Healthcare Spending?, 4 Wm & Mary Pol’y Rev. 319 (2013) (with Morgan A. Muir & Stephanie A. Alessi). FULLTEXT
  • Group Health's Participation In A Shared Decision-Making Demonstration Yielded Lessons, Such As Role Of Culture Change, 32 Health Aff. 294 (2013) (with Benjamin Moulton). URL
  • Cell-Free Fetal DNA Testing for Fetal Aneuploidy and Beyond: Clinical Integration Challenges in the U.S. Context, 27 Hum. Reprod. 3123 (Nov. 2012) (with Megan Allyse, Lauren C. Sayres, Mary E. Norton & Mildred K. Cho). URL
  • Living ART, 23 Hastings Women's L.J. 73 (2012). FULLTEXT
  • Not this Child: Constitutional Questions in Regulating Non-Invasive Prenatal Genetic Diagnosis and Selective Abortion, 60 UCLA L. Rev. 2 (2012). FULLTEXT
  • And Genetic Testing for All . . . The Coming Revolution in Non-Invasive Prenatal Genetic Testing, 42 Rutgers L.J. 599 (2011). FULLTEXT SSRN
  • The Potential of Shared Decision Making to Reduce Health Disparities, 39 J.L. Med. & Ethics 30 (2011) (with Mark H. Eckman & Benjamin W. Moulton). FULLTEXT
  • Aligning Ethics with Medical Decision-Making: The Quest for Informed Patient Choice, 38 J.L. Med. & Ethics 85 (2010) (with Benjamin Moulton). FULLTEXT
  • Duty to the Unborn: A Response to Smolensky, 60 Hastings L.J. 377 (2008). FULLTEXT SSRN
  • Predicting Probability: Regulating the Future of Preimplantation Genetic Screening, 8 Yale J. Health Pol'y L. & Ethics 283 (2008). FULLTEXT SSRN
  • Toward the "Tipping Point": Decision Aids and Informed Patient Choice, 26 Health Aff. 716 (May/June 2007) (with Annette M. O'Connor, John E. Wennberg, France Legare, Hilary A. Llewellyn–Thomas, Benjamin W. Moulton, Karen R. Sepucha, & Andrea G. Sodano). FULLTEXT
  • Rethinking Informed Consent: The Case for Shared Medical Decision-Making, 32 Am. J.L. & Med. 429 (2006) (with Benjamin W. Moulton). FULLTEXT SSRN
Chapters In Books

  • ERISA as a Barrier for State Health Care Transparency Efforts, in Transparency in Health and Health Care 301 (Carmel Shachar, I. Glenn Cohen, Holly Fernandez Lynch, & Barbara J. Evans eds., Cambridge Univ. Press 2019) (with Erin C. Fuse Brown). URL
Newspaper & Magazine Articles

  • Promoting Health Care Transparency via State Legislative Efforts, JAMA Health Forum, Mar. 9, 2020 (with Roslyn Murray & Suzanne Delbanco). URL
  • Politics and Fetal Diagnostics Collide, Nature, Nov. 1, 2012, at 33.
Other Publications

  • A Step Forward for Health Care Market Oversight: Oregon Health Authority’s Health Care Market Oversight Program, Milbank Memorial Fund Report (2023) (with Robin Davison et al.). URL
  • Markets or Monopolies? Considerations for Addressing Health Care Consolidation in California, CHCF Issue Brief (Dec. 2021) (with Katherine L. Gudiksen & Amy Y. Gu). URL
  • Mitigating the Price Impacts of Health Care Provider Consolidation, Milbank Memorial Fund Issue Brief (Sept. 2021) (with Katherine L. Gudiksen & Alexandra D. Montague). URL
  • State Action to Oversee Consolidation of Health Care Providers, Milbank Memorial Fund Issue Brief (August 2021) (with Alexandra D. Montague & Katherine L. Gudiksen). URL
  • Who Can Rein in Health Care Prices? State and Federal Efforts to Address Health Care Provider Consolidation, Milbank Memorial Fund Issue Brief (June 2021) (with Katherine L. Gudiksen & Alexandra D. Montague). URL
  • Addressing Health Care Market Consolidation and High Prices, Urban Institute (January 2020) (with Robert A. Berenson, Katherine L. Gudiksen, Roslyn Murray & Adele Shartzer). URL
  • Navigating Legal Challenges to State Efforts to Control Drug Prices: Pharmacy Benefit Manager Regulation, Anti-Price-GougingLaws, and Price Transparency, National Academy for State Health Policy (Sept. 19, 2019) (with Katherine L. Gudiksen & Samuel M. Chang). URL
  • The Secret of Health Care Prices: Why Transparency Is in the Public Interest, California Health Care Foundation (July 2019) (with Katherine L. Gudiksen & Samuel M. Chang). URL
  • The Legal Dimensions of Genomic Sequencing in Newborn Screening, The Ethics of Sequencing Newborns: Recommendations and Reflections, special report, Hastings Center Report 48, no. 4 (2018) (with Rachel L. Zacharias & Monica E. Smith). URL
  • All-Payer Claims Databases: The Balance between Big Healthcare Data Utility and Individual Health Privacy, The Source: UCSF/UC Hastings Consortium on Law, Science and Health Policy (2017) (with Andrew Kelly). URL
  • State Actions to Promote and Restrain Commercial Accountable Care Organizations, Milbank Memorial Fund Report (October 2015) (with Ann Hollingshead, Brent D. Fulton, & Joshua Rushakoff). URL
Dissertations & Theses

  • The Regulation of Individual Autonomy in Medical Decision–Making (May 2008) (unpublished Ph. D. thesis, Harvard University) (on file with Harvard University).

Search the Database

Search our faculty's bibliographies.

Get Help

Help using Faculty Bibliographies Search.

Faculty Services Librarian Tony Pelczynski compiles the Faculty Bibliographies database. Citation information is updated twice a year.